The Organization’s MissionDeveloping innovative medicines to improve the lives of those impacted by DMD around the world.
Is This Your Company?
Work at Sarepta Therapeutics? Share your experience anonymously.
What do you like about working for Sarepta Therapeutics?
Sarepta Therapeutics is ranked #25 on the Best Technology Companies to Work For in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
Read more about how we rank companies.
Sarepta Therapeutics Salaries By Job Title
On average, employees at Sarepta Therapeutics stay with the company for 2.7 years. Employees most commonly join Sarepta Therapeutics after leaving Intel.
|Average Length of Employment|
MannKind Corporation3.8 years
Emergent BioSolutions3.0 years
Sarepta Therapeutics2.7 years
bluebird bio1.6 years
|Top Employers Before Sarepta Therapeutics|
Manchester University12.9 %
Kelly Services9.7 %
Help us make this company more transparent.
$100M - $1B
Have you worked at Sarepta Therapeutics? Help other job seekers by rating Sarepta Therapeutics.
Douglas Ingram (ceo)
Claiming and updating your company profile on Zippia is free and easy.
You can find out what it is like to work at Sarepta Therapeutics, also known as SAREPTA THERAPEUTICS INC, Sarepta Therapeutics, Sarepta Therapeutics Inc and Sarepta Therapeutics, Inc..
Zippia gives an in-depth look into the details of Sarepta Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Sarepta Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Sarepta Therapeutics. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Sarepta Therapeutics and its employees or that of Zippia.